These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 5077472)

  • 1. Serum and urine fibrinogen-fibrin-related antigen (F.R.-antigen) levels in renal disease.
    Briggs JD; Prentice CR; Hutton MM; Kennedy AC; McNicol GP
    Br Med J; 1972 Oct; 4(5832):82-5. PubMed ID: 5077472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinogen-fibrin degradation product levels in different types of intravascular haemolysis.
    Slater SD; Prentice CR; Bain WH; Briggs JD
    Br Med J; 1973 Sep; 3(5878):471-3. PubMed ID: 4726152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum and urine F.R.-antigen in renal disease.
    Wardle EN
    Br Med J; 1972 Nov; 4(5837):427-8. PubMed ID: 4637171
    [No Abstract]   [Full Text] [Related]  

  • 4. Urinary excretion of C3 antigen in glomerulonephritis.
    Williams BD; Clarkson AR; Row PG; Groves RJ; Cameron JS
    Br Med J; 1974 Oct; 4(5935):21-3. PubMed ID: 4425816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific identification of urinary fibrinogen, fibrinogen degradation products, and cross-linked fibrin degradation products in renal diseases and after renal allotransplantation.
    Scott WL; Francis CW; Knutson DW; Marder VJ
    J Lab Clin Med; 1986 Jun; 107(6):534-43. PubMed ID: 3519810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunologically reactive equivalents of fibrinogen in sera and urine of children with renal disease.
    Ekert H; Barratt TM; Chantler C; Turner MW
    Arch Dis Child; 1972 Feb; 47(251):90-6. PubMed ID: 5018662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary fibrinogen derivative excretion and intraglomerular fibrin deposition in glomerulonephritis.
    Naish P; Evans DJ; Peters DK
    Br Med J; 1974 Mar; 1(5907):544-6. PubMed ID: 4593708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum levels of fibrin-fibrinogen degradation products in the haemolytic-uraemic syndrome.
    Uttley WS
    Arch Dis Child; 1970 Aug; 45(242):587-9. PubMed ID: 5472689
    [No Abstract]   [Full Text] [Related]  

  • 9. Fibrin breakdown products and fibrinolysis in renal disease.
    Wardle EN; Taylor G
    J Clin Pathol; 1968 Mar; 21(2):140-6. PubMed ID: 5697045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary fibrinogen and fibrin fragments in children with renal disease.
    Yoshioka K; Iseki T; Akano N; Uraoka Y; Miyata H; Maki S
    Nephron; 1982; 32(2):135-9. PubMed ID: 7177290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary fibrin-fibrinogen degradation products in nephrotic syndrome.
    Hall CL; Pejhan N; Terry JM; Blainey JD
    Br Med J; 1975 Feb; 1(5955):419-22. PubMed ID: 803853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary excretion of fibrinogen-fibrin-related antigen in glomerulonephritis: effect of indomethacin.
    Dotremont G; Vermylen J; Donati MB; Van Damme B; Michielsen P
    Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):829-44. PubMed ID: 4803317
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum and urinary fibrin-fibrinogen degradation products in glomerulonephritis.
    Clarkson AR; MacDonald MK; Petrie JJ; Cash JD; Robson JS
    Br Med J; 1971 Aug; 3(5772):447-51. PubMed ID: 5567767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrinogen and FDP-E antigen deposits in nephritic kidneys.
    Nagai T; Kawai C
    Nephron; 1978; 21(1):16-26. PubMed ID: 351448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the origin of urinary fibrin-fibrinogen-related antigen in glomerulonephritis.
    Bone JM; Sherman LA; Valdes AJ; Lubowitz H
    J Lab Clin Med; 1977 May; 89(5):1043-52. PubMed ID: 558266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The significance of microangiopathic haemolytic anaemia in accelerated hypertension.
    Sevitt LH; Naish P; Baker LR; Bulpitt CJ; Archer DF; Nelson DA; Peters DK
    Br J Haematol; 1973 Apr; 24(4):503-10. PubMed ID: 4715145
    [No Abstract]   [Full Text] [Related]  

  • 17. Urinary fibrin/fibrinogen degradation products measured using an anti-fibrinogen antibody predict orthostatic proteinuria.
    Kanai H; Sawanobori E; Kobayashi A; Goto M; Higashida K; Sugita K
    Pediatr Int; 2018 Jul; 60(7):639-644. PubMed ID: 29654610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Origin of urinary fibrin/fibrinogen degradation products in glomerulonephritis.
    Ekberg M; Pandolfi M
    Br Med J; 1975 Apr; 2(5961):17-9. PubMed ID: 48398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrin-fibrinogen degradation products in children with renal disease.
    Ambrus JL; Baliah T; Ambrus CM; Mink IB; Murphy GP
    N Y State J Med; 1974 Jul; 74(8):1396-402. PubMed ID: 4277485
    [No Abstract]   [Full Text] [Related]  

  • 20. Fibrin-fibrinogen degradation products in children with renal disease.
    Uttley WS; Maxwell H; Cash JD
    Arch Dis Child; 1974 Feb; 49(2):137-42. PubMed ID: 4817446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.